Cytek Biosciences (CTKB) Total Current Liabilities (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Total Current Liabilities came in at $80.9 million in Q1 2026, up 19.57% YoY from $67.7 million in Q1 2025, and up 4.02% on a QoQ basis from $77.8 million in Q4 2025.
Cytek Biosciences (CTKB) Total Current Liabilities (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Total Current Liabilities data on file, last reported at $80.9 million in Q1 2026.
- Quarterly Total Current Liabilities rose 19.57% year-over-year to $80.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $80.9 million (up 19.57% YoY) and the FY2025 annual result came in at $77.8 million, up 14.99% from the prior year.
- Total Current Liabilities climbed to $80.9 million in Q1 2026, from $77.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $80.9 million in Q1 2026 to a low of $41.5 million in Q3 2022.
- A 5-year average of $59.6 million and a median of $56.5 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 50.36% — and 2024, when it fell 2.26%.
- Tracing CTKB's Total Current Liabilities over 5 years: stood at $49.0 million in 2022, then climbed by 14.65% to $56.2 million in 2023, then rose by 20.34% to $67.7 million in 2024, then rose by 14.99% to $77.8 million in 2025, then grew by 4.02% to $80.9 million in 2026.
- The last three Total Current Liabilities figures came in at $80.9 million (Q1 2026), $77.8 million (Q4 2025), and $75.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Cytek Biosciences | 602.64 Mn | 528.79 Mn | 28.34 Mn | 84.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 84.34 Mn |
| Mar 31, 2026 | 80.94 Mn |
| Dec 31, 2025 | 77.80 Mn |
| Sep 30, 2025 | 75.21 Mn |
| Jun 30, 2025 | 73.27 Mn |
| Mar 31, 2025 | 67.69 Mn |
| Dec 31, 2024 | 67.66 Mn |
| Sep 30, 2024 | 62.80 Mn |
| Jun 30, 2024 | 52.38 Mn |
| Mar 31, 2024 | 55.57 Mn |
| Dec 31, 2023 | 56.23 Mn |
| Sep 30, 2023 | 58.69 Mn |
| Jun 30, 2023 | 53.59 Mn |
| Mar 31, 2023 | 56.52 Mn |
| Dec 31, 2022 | 49.04 Mn |
| Sep 30, 2022 | 41.49 Mn |
| Jun 30, 2022 | 42.35 Mn |
| Mar 31, 2022 | 42.80 Mn |
| Dec 31, 2021 | 33.18 Mn |
| Sep 30, 2021 | 30.01 Mn |